Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

The utility of the International Working Group (IWG) 2006 response criteria for myelodysplastic syndromes (MDS) as a surrogate endpoint for outcomes is unclear. We assessed the validity of the IWG 2006 response criteria in a large cohort of higher‐risk MDS patients (pts) treated at centers from the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Komrokji, Rami S., Al Ali, Najla H, Sallman, David, Padron, Eric, DeZern, Amy E., Barnard, John, Roboz, Gail J., Garcia‐Manero, Guillermo, List, Alan, Steensma, David P., Sekeres, Mikkael A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877342/
https://ncbi.nlm.nih.gov/pubmed/33350168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3608
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi